27.04.2012
- Pharmaceutical firm Shire posted a 20% rise in first-quarter earnings on Thursday, just beating market expectations, as its drugs to treat hyperactivity again lifted market share...
24.04.2012
- Rhodia, member of the Solvay group, and Tantalus Rare Earths are pleased to announce the signing of a Letter of Intent ("LOI") relating to technical cooperation for the development...
24.04.2012
- Seven months after the acquisition of Rhodia, Solvay today presented the group's strategic vision focused on value creation and its profitability ambition for 2016. The major...
23.04.2012
- An official ceremony was held on April 21, 2012 to mark the groundbreaking for Evonik's new hydrogen peroxide plant in China. The plant is scheduled to go online, with a planed...
23.04.2012
- Europe's largest drugs distributor Celesio is set to significantly boost its stake in Brazil's largest drugs distributor Panpharma from currently 50.1%, two people with the matter...
20.04.2012
- Roche dropped its bid to buy the gene-sequencing leader Illumina this week after Illumina's shareholders made it clear at the company's annual meeting that the terms were...
19.04.2012
- Chemical maker Albemarle's first quarter earnings rose, and beat Wall Street's expectations, on strong sales of catalysts used by petroleum refiners. Sales of specialty materials...
18.04.2012
- KitoZyme, the Belgian maker of food supplements to tackle problems ranging from high cholesterol to dry skin, is planning to list in Brussels in three to four years, as long as...
18.04.2012
- Cheap natural gas from North American shale developments and growth in Latin American markets likely helped U.S. chemical makers offset weak first-quarter demand from Europe, which...